Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

Bekondi, 2006, Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus, Int J Infect Dis, 10, 387, 10.1016/j.ijid.2005.07.004

Bogaerts, 1999, AIDS-associated cryptococcal meningitis in Rwanda (1983–1992): epidemiologic and diagnostic features, J Infect, 39, 32, 10.1016/S0163-4453(99)90099-3

Gordon, 2000, Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal, Clin Infect Dis, 31, 53, 10.1086/313910

Helbok, 2006, Chronic meningitis in Thailand. Clinical characteristics, laboratory data and outcome in patients with specific reference to tuberculosis and cryptococcosis, Neuroepidemiology, 26, 37, 10.1159/000089236

Heyderman, 1998, Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe [see comment], Clin Infect Dis, 26, 284, 10.1086/516298

Hovette, 1999, Cryptococcal meningitis in AIDS patients: an emerging opportunistic infection in Senegal, Trans R Soc Trop Med Hyg, 93, 368, 10.1016/S0035-9203(99)90119-0

Schutte, 2000, The impact of HIV on meningitis as seen at a South African Academic Hospital (1994 to 1998), Infection, 28, 3, 10.1007/PL00012241

Dromer, 2004, Epidemiology of HIV-associated cryptococcosis in France (1985–2001): comparison of the pre and post-HAART eras [see comment], AIDS, 18, 555, 10.1097/00002030-200402200-00024

Kaplan, 2000, Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy, Clin Infect Dis, 30, S5, 10.1086/313843

Mirza, 2003, The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992–2000, Clin Infect Dis, 36, 789, 10.1086/368091

van Elden, 2000, Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy, AIDS, 14, 2787, 10.1097/00002030-200012010-00019

Chariyalertsak, 2001, Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994–1998: regional variation and temporal trends, Clin Infect Dis, 32, 955, 10.1086/319348

d'Arminio Monforte, 2004, Changing incidence of central nervous system diseases in the EuroSIDA cohort [see comment], Ann Neurol, 55, 320, 10.1002/ana.10827

Dilley, 2005, The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991–2003, AIDS, 19, 634, 10.1097/01.aids.0000163944.39306.7c

French, 2002, Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults, AIDS, 16, 1031, 10.1097/00002030-200205030-00009

Kim, 2003, Epidemiology and clinical features of HIV infection/AIDS in Korea, Yonsei Med J, 44, 363, 10.3349/ymj.2003.44.3.363

Klotz, 2007, Clinical features of HIV/AIDS patients presenting to an inner city clinic in Ho Chi Minh City, Vietnam, Int J STD AIDS, 18, 482, 10.1258/095646207781147265

Kong, 2007, Opportunistic infections and HIV clinical disease stage among patients presenting for care in Phnom Penh, Cambodia, Southeast Asian J Trop Med Public Health, 38, 62

Kumarasamy, 2003, Natural history of human immunodeficiency virus disease in southern India, Clin Infect Dis, 36, 79, 10.1086/344756

Mbanya, 2002, Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective, Int J Infect Dis, 6, 134, 10.1016/S1201-9712(02)90075-5

Oh, 1999, Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea, Clin Infect Dis, 29, 1524, 10.1086/313516

Sacktor, 2001, HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998, Neurology, 56, 257, 10.1212/WNL.56.2.257

Vajpayee, 2003, Spectrum of opportunistic infections and profile of CD4+ counts among AIDS patients in North India, Infection, 31, 336, 10.1007/s15010-003-3198-y

Wolff, 2005, The Chilean AIDS cohort: a model for evaluating the impact of an expanded access program to antiretroviral therapy in a middle-income country – organization and preliminary results, J Acquir Immune Defic Syndr, 40, 551, 10.1097/01.qai.0000185573.98472.f8

McCarthy, 2006, Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence, AIDS, 20, 2199, 10.1097/QAD.0b013e3280106d6a

Hajjeh, 1999, Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group [see comment], J Infect Dis, 179, 449, 10.1086/314606

Mayanja-Kizza, 1998, Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS [see comment], Clin Infect Dis, 26, 1362, 10.1086/516372

van der Horst, 1997, Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group [see comment], N Engl J Med, 337, 15, 10.1056/NEJM199707033370103

Gumbo, 2002, Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome, Pediatr Infect Dis J, 21, 54, 10.1097/00006454-200201000-00012

Khanna, 2000, Cryptococcosis in the immunocompromised host with special reference to AIDS, Indian J Chest Dis Allied Sci, 42, 311

Lara-Peredo, 2000, Cryptococcal infection in an HIV-positive Ugandan population, J Infect, 41, 195, 10.1053/jinf.2000.0697

Lortholary, 2006, Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy, AIDS, 20, 2183, 10.1097/01.aids.0000252060.80704.68

Mwaba, 2001, Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions, Postgrad Med J, 77, 769, 10.1136/pgmj.77.914.769

Okongo, 1998, Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda, Int J Epidemiol, 27, 698, 10.1093/ije/27.4.698

Sun, 2006, Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active antiretroviral therapy, Clin Microbiol Infect, 12, 381, 10.1111/j.1469-0691.2006.01367.x

Corbett, 2002, Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus, Clin Infect Dis, 34, 1251, 10.1086/339540

Hamill, 2006, Free fluconazole for cryptococcal meningitis: too little of a good thing? [comment], Clin Infect Dis, 43, 1074, 10.1086/507900

Tanner, 1994, Comparison of commercial kits for detection of cryptococcal antigen, J Clin Microbiol, 32, 1680, 10.1128/JCM.32.7.1680-1684.1994

Chariyalertsak, 2002, A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand, Clin Infect Dis, 34, 277, 10.1086/338154

McKinsey, 1999, Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group, Clin Infect Dis, 28, 1049, 10.1086/514744

Powderly, 1995, A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group [see comment], N Engl J Med, 332, 700, 10.1056/NEJM199503163321102

Smith, 2001, A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection, HIV Med, 2, 78, 10.1046/j.1468-1293.2001.00060.x

Driver, 1995, Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia?, J Acquir Immune Defic Syndr Hum Retrovirol, 9, 168

Wong, 2007, Cryptococcal pneumonia in African miners at autopsy, Int J Tuberculosis Lung Dis, 11, 528

Tassie, 2003, Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda, J Acquir Immune Defic Syndr, 33, 411, 10.1097/00126334-200307010-00019